Sweeney & Michel, LLC Amgen Inc Transaction History
Sweeney & Michel, LLC
- $229 Billion
- Q1 2025
A detailed history of Sweeney & Michel, LLC transactions in Amgen Inc stock. As of the latest transaction made, Sweeney & Michel, LLC holds 5,190 shares of AMGN stock, worth $1.62 Million. This represents 0.64% of its overall portfolio holdings.
Number of Shares
5,190
Previous 5,067
2.43%
Holding current value
$1.62 Million
Previous $1.63 Billion
10.76%
% of portfolio
0.64%
Previous 0.64%
Shares
7 transactions
Others Institutions Holding AMGN
# of Institutions
3,203Shares Held
422MCall Options Held
7.05MPut Options Held
6.39M-
Vanguard Group Inc Valley Forge, PA52.7MShares$16.4 Billion0.25% of portfolio
-
Black Rock Inc. New York, NY46MShares$14.3 Billion0.33% of portfolio
-
State Street Corp Boston, MA29.4MShares$9.17 Billion0.31% of portfolio
-
Morgan Stanley New York, NY14.6MShares$4.54 Billion0.27% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA13.2MShares$4.11 Billion0.65% of portfolio
About AMGEN INC
- Ticker AMGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 534,931,008
- Market Cap $167B
- Description
- Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...